Previous studies showed that overexpression of POSTN predicted a poor prognosis in non-small cell lung cancer and colorectal cancer and suggested that POSTN could be a regulator of inflammation in the tumor microenvironment and a potential therapeutic target in lung and colorectal cancers [51, 52]. This evidence concerns the gene POSTN and neoplasm.